Results 61 to 70 of about 103,759 (240)
Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report
Journal of Nobel Medical College, 2021 Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the ...
Sushmita Khanal, Sunil Babu Khanal
doaj +1 more source
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia [PDF]
, 2018 Background: A number of Zika vaccine platforms are currently being investigated, some of which have entered clinical trials. We sought to evaluate the cost-effectiveness of a potential Zika vaccine candidate under the WHO Vaccine Target Product Profile ...
Moghadas, Seyed +2 more
core +2 more sources
Guillain-Barré syndrome following COVID-19: new infection, old complication?
Journal of Neurology, 2020 The coronavirus disease-2019 (COVID-19) pandemic originated in Wuhan (China) on December 2019. So far, more than 1,500,000 cases have been confirmed worldwide (> 150,000 cases in Italy) [1].
M. Padroni +8 more
semanticscholar +1 more source
Case Reports in Transplantation, 2017 Guillain-Barré Syndrome (GBS) is a common acute autoimmune polyneuropathy in adults. There have been few reported cases of Guillain-Barré Syndrome associated with active cytomegalovirus (CMV) infection in renal transplant recipients.
Massini Merzkani +2 more
doaj +1 more source
Plasmaferesis Sebagai Terapi Sindrom Guillain-Barre Berat pada Anak
Sari Pediatri, 2016 Plasmaferesis atau plasma exchange merupakan salah satu pilihan terapi bagi sindrom Guillain-Barre berat. Beberapa penelitian menunjukkan bahwa plasmaferesis dan imunoglobulin intravena (IVIg) sebagai terapi sindrom Guillain-Barre memiliki efektivitas ...
Vimaladewi Lukito +3 more
doaj +1 more source
Guillain–Barré syndrome variants: a grave complication of bariatric surgery
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022 Background Guillain–Barré syndrome is an acquired inflammatory disease of the peripheral nervous system. It is the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month.
Raseel A. Aljthalin, Alawi A. Al-Attas
doaj +1 more source
The Ultimate Poker Face: A Case Report of Facial Diplegia, a Guillain-Barré Variant [PDF]
, 2020 Introduction: Facial diplegia, a rare variant of Guillain-Barré syndrome (GBS), is a challenging diagnosis to make in the emergency department due to its resemblance to neurologic Lyme disease.Case report: We present a case of a 27-year-old previously ...
Lowe, Joshua, Pfaff, James
core
Pathology of "landry-guillain-barré syndrome" in children, prevailing in the regions surrounding the Inland Sea of Japan [PDF]
, 1956 Histopathological investigations were carried out on five fatal cases of a type of polyneuritis of unknown etiology diagnosed as Landry-Guillain-Barre syndrome, which endemically occurred in children in the regions surrounding the Inland Sea of Japan ...
Akagi, Seiji, Oda, Takuzo
core +1 more source
Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review
Neurological Therapeutics, 2021 Guillain–Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that typically develops within 4 weeks after infection. In addition to conventional infectious diseases with which we are familiar, emerging infectious diseases ...
H. Koike, A. Chiba, M. Katsuno
semanticscholar +1 more source
Arthritis Care &Research, EarlyView.Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source